Mostrar o rexistro simple do ítem

dc.contributor.authorTyminska, Agata
dc.contributor.authorOzieranski, Krzysztof
dc.contributor.authorBrociek, Emil
dc.contributor.authorKaplon-Cieslicka, Agnieszka
dc.contributor.authorBalsam, Pawel
dc.contributor.authorMarchel, Michal
dc.contributor.authorCrespo-Leiro, María Generosa
dc.contributor.authorMaggioni, Aldo P.
dc.contributor.authorDrozdz, Jaroslaw
dc.contributor.authorOpolski, Grzegorz
dc.contributor.authorGrabowski, Marcin
dc.date.accessioned2023-02-17T10:33:27Z
dc.date.available2023-02-17T10:33:27Z
dc.date.issued2022-06-06
dc.identifier.citationTymińska A, Ozierański K, Brociek E, Kapłon-Cieślicka A, Balsam P, Marchel M, Crespo-Leiro MG, Maggioni AP, Drożdż J, Opolski G, Grabowski M. Fifteen-year differences in indications for cardiac resynchronization therapy in international guidelines—insights from the heart failure registries of the European Society of Cardiology. J Clin Med. 2022 Jun 6;11(11):3236.es_ES
dc.identifier.issn2077-0383
dc.identifier.urihttp://hdl.handle.net/2183/32522
dc.description.abstract[Abstract] Cardiac resynchronization therapy (CRT) applied to selected patients with heart failure (HF) improves their prognosis. In recent years, eligibility criteria for CRT have regularly changed. This study aimed to investigate the changes in eligibility of real-life HF patients for CRT over the past fifteen years. We reviewed European and North American guidelines from this period and applied them to HF patients from the ESC-HF Pilot and ESC-Long-Term Registries. Taking into consideration the criteria assessed in this study (including all classes of recommendations i.e., class I, IIa and IIb, as well as patients with AF and SR), the 2013 (ESC) guidelines would have qualified the most patients for CRT (266, 18.3%), while the 2015 (ESC) guidelines would have qualified the least (115, 7.9%; p-value for differences between all analyzed papers <0.0001). There were only 26 patients (1.8%) who would be eligible for CRT using the class I recommendations across all of the guidelines. These results demonstrate the variability in recommendations for CRT over the years. Moreover, this data indicates underuse of this form of pacing in HF and highlights the need for more studies in order to improve the outcomes of HF patients and further personalize their management.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.relation.urihttps://doi.org/10.3390/jcm11113236es_ES
dc.rightsAtribución 3.0 Españaes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectCardiac resynchronization therapyes_ES
dc.subjectCardiomyopathyes_ES
dc.subjectHeart failurees_ES
dc.subjectLeft bundle branch blockes_ES
dc.titleFifteen-year differences in indications for cardiac resynchronization therapy in international guidelines—insights from the heart failure registries of the European Society of Cardiologyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessinfo:eu-repo/semantics/openAccesses_ES
UDC.journalTitleJournal of Clinical Medicinees_ES
UDC.volume11es_ES
UDC.issue11es_ES
UDC.startPage3236es_ES


Ficheiros no ítem

Thumbnail
Thumbnail
Thumbnail

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem